Press Releases
ERYTECH Pharma Signs Licensing and Distribution Agreement with Orphan...
ERYTECH Pharma, a late stage biopharmaceuticals company focused on orphan oncology and rare diseases, announced today that it has entered into a definitive agreement...
Press Releases
Genzyme’s Once-Daily, Oral AUBAGIO® Approved in Australia for Treatment...
Genzyme, aSanofi company, announced today that the Australian Therapeutic Goods Administration (TGA) has approved AUBAGIO® (teriflunomide) 14 mg as a new once-daily, oral treatment...
Press Releases
PerkinElmer Establishes New Direct Operations in Southern Africa to...
PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, announced today that it has opened direct...
Press Releases
Diffusion Pharmaceuticals Successfully Completes Phase I Brain Cancer Trial
Diffusion Pharmaceuticals LLC, a biotechnology company developing innovative cancer treatments, today announced that it has successfully completed a Phase I clinical trial of its...
Press Releases
State of the Cure Report Finds Funding of Cure...
On November 19, 2012, the Juvenile Diabetes Cure Alliance announced the release of their annual research report, State of the Cure, which is the...
Press Releases
BioTime and BioTime Acquisition Corporation Announce Combined $10 Million...
BioTime, Inc. and its recently formed subsidiary BioTime Acquisition Corporation (BAC) jointly announced today that they have entered into a non-binding letter of intent...
Press Releases
GE Healthcare scientist paired with Cardiff MP to share...
Dr. Michelle Janas from GE Healthcare Life Sciences recently swapped a lab coat for legislation, when she visited Jenny Willott MP at the House...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.